Research Roundup ยท 2026

Research Notes: Tysabri and Progressive Multifocal Leukoencephalopathy risk: what studies show

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Primary topic reference

Understanding Tysabri and Progressive Multifocal Leukoencephalopathy risk: what studies show

A focused look at the background, context, and key sources on this subject.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.